| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/18/1996 | DE4425098A1 7-0-Carbamoyl-Heptose-Derivate, Verfahren zu deren Herstellung und deren Verwendung sowie Screening-Verfahren zu deren Bestimmung 7-0-carbamoyl-heptose derivatives, processes for their preparation and their use, and screening procedures for their determination |
| 01/18/1996 | DE4424714A1 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff New chemical compound, their preparation and their use as Arnzneistoff |
| 01/18/1996 | DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe |
| 01/18/1996 | DE4424678A1 Dioxo-thiopyrano-pyridin-carbonsäure-derivate Dioxo-thiopyrano-pyridine-carboxylic acid derivatives |
| 01/18/1996 | DE4424369A1 Pyrido[3,2,1.i,j][3,1]benzoxazinderivate Pyrido [3,2,1.i, j] [3,1] benzoxazine derivatives |
| 01/18/1996 | CA2194371A1 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
| 01/18/1996 | CA2194277A1 Canptothecin drug combinations and medicaments with reduced side effects |
| 01/18/1996 | CA2194237A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | CA2194216A1 Carbamazepine medicament with retarded active substance release |
| 01/18/1996 | CA2193963A1 Stereochemical wortmannin derivatives |
| 01/18/1996 | CA2193489A1 Anti-hiv triple combination |
| 01/18/1996 | CA2193473A1 Method and medicine for alleviating jet lag |
| 01/18/1996 | CA2191775A1 Pla2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 01/18/1996 | CA2191696A1 Cancer therapy using lymphotoxin |
| 01/17/1996 | EP0692535A1 Oligonucleotides to inhibit the role of isoprenyl protein transferases |
| 01/17/1996 | EP0692487A1 Cholestasis ameliorant |
| 01/17/1996 | EP0692484A1 Benzothiadiazine derivative process for its preparation and pharmaceutical compositions containing it |
| 01/17/1996 | EP0692472A1 Alpha-(4-chlorophenyl)- 4-(4-fluorophenylmethyl)-piperidine-1 -ethanol esters, their preparation and therapeutical use |
| 01/17/1996 | EP0692258A1 Periwinkle seed extract and composition containing it |
| 01/17/1996 | EP0692253A1 Prophylatic for domestic animal mastitis |
| 01/17/1996 | EP0692251A1 Use of methotrexate for the manufacture of a medicament for the treatment of lung capillary leak |
| 01/17/1996 | EP0692250A2 Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields |
| 01/17/1996 | EP0692249A1 Compounds bearing one or more oxime functions, stabilized in aqueous solution, process to prepare them, and their use as drugs |
| 01/17/1996 | EP0692237A1 Surface active agents free oil in water emulsion, stabilized by hollow thermoplastic particles |
| 01/17/1996 | EP0692192A1 Alcoholic disinfecting agent preparation and use thereof |
| 01/17/1996 | EP0691987A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 01/17/1996 | EP0691986A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS |
| 01/17/1996 | EP0691979A1 Novel 5'-substituted nucleosides and oligomers produced therefrom |
| 01/17/1996 | EP0691977A1 Oligonucleotides with amide linkages replacing phosphodiester linkages |
| 01/17/1996 | EP0691976A1 Anticoagulant compounds |
| 01/17/1996 | EP0691973A1 THIENO-INDOLE DERIVATIVES AS 5HT2c AND 5HT2b ANTAGONISTS |
| 01/17/1996 | EP0691972A1 FURO 3,2-b]PYRIDINES AND THIENO 3,2-b]PYRIDINES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 01/17/1996 | EP0691971A1 7-azabicyclo- 2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents |
| 01/17/1996 | EP0691970A1 Imidazoloquinoxalinone derivatives as eaa antagonists |
| 01/17/1996 | EP0691969A1 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE |
| 01/17/1996 | EP0691966A1 Quinolines as type iv phosphodiesterase inhibitors |
| 01/17/1996 | EP0691964A1 (3-ketotetrahydrofuran-2-yl)ethanal derivatives and a method for their preparation |
| 01/17/1996 | EP0691962A1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance |
| 01/17/1996 | EP0691960A1 Antipsychotic benzimidazole derivatives |
| 01/17/1996 | EP0691959A1 Heterocyclic derivatives as platelet aggregation inhibitors |
| 01/17/1996 | EP0691956A1 3-phenyl-1,2,5,6-tetrahydropyridine derivatives as sedatives |
| 01/17/1996 | EP0691953A1 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors |
| 01/17/1996 | EP0691853A1 ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION |
| 01/17/1996 | EP0691852A1 Prodrugs with enhanced penetration into cells |
| 01/17/1996 | EP0691849A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d |
| 01/17/1996 | EP0691847A1 Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
| 01/17/1996 | EP0691846A1 Imidazolo-quinoxalinones for treating diseases of the central nervous system |
| 01/17/1996 | EP0691845A1 Use of cis- or transurocamic acid for the treatment of photodermatoses and immunogenic skin diseases |
| 01/17/1996 | EP0691844A1 Method for treating amyloidosis |
| 01/17/1996 | EP0691843A1 RETARDED-ACTION MICROTABLET MADE OF -g(b)-PHENYLPROPIOPHENONE DERIVATIVES |
| 01/17/1996 | EP0691842A1 Lidocaine aerosol anaesthetic |
| 01/17/1996 | EP0691814A1 Method and composition for treatment of osteoporosis |
| 01/17/1996 | EP0691813A1 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules elam-1 (e-selectin) and lecam-1 (l-selectin) |
| 01/17/1996 | EP0679057A4 Structured lipids. |
| 01/17/1996 | EP0674646A4 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use. |
| 01/17/1996 | EP0635014B1 Indole derivatives as 5-ht1-like agonists |
| 01/17/1996 | EP0602028B1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them |
| 01/17/1996 | EP0537313B1 Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity |
| 01/17/1996 | EP0522128B1 Water-dispersible tablets |
| 01/17/1996 | EP0515544B1 Steroid sulphatase inhibitors |
| 01/17/1996 | EP0493480B1 Dehydrodidemnin b |
| 01/17/1996 | CN1115182A Antithrombotic |
| 01/17/1996 | CN1115181A Process for the preparation of 9-amino camptothecin |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1114960A Azierythromycin crystal and its preparation method |
| 01/17/1996 | CN1114959A Novel quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime) pyrrolidine substituent and processes for preparing thereof |
| 01/17/1996 | CN1114957A New (thia)cycloalkyl|b¨indole compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
| 01/17/1996 | CN1114903A A styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
| 01/17/1996 | CN1114886A Bones and tendon recovery cream |
| 01/17/1996 | CN1114882A Medicine for the topical treatment of skin |
| 01/17/1996 | CN1114880A Novel treatment |
| 01/17/1996 | CN1114879A Method of administering azithromycin |
| 01/17/1996 | CN1114878A Preparation of prevention and cure of cardio-vascular diseases |
| 01/17/1996 | CN1114876A Use of a spin trap in a cosmetic or dermatological composition |
| 01/17/1996 | CN1030702C 芪衍生物 Stilbene derivatives |
| 01/17/1996 | CN1030701C Indole derivatives and process for production thereof |
| 01/17/1996 | CN1030687C Preparation method of urethra feed medicine agent |
| 01/16/1996 | US5484951 Treatment of aids, herpes, cytomegalo virus, antitumor agents |
| 01/16/1996 | US5484946 Cyclization and dehydration a methionine derivative |
| 01/16/1996 | US5484944 Anxiety, sleep, memory |
| 01/16/1996 | US5484942 Chemical intermediates for compounds that are antagonist for substance p such as analgesics, antiinflammatory agents, cns agents, antispasmodics or immunological effects |
| 01/16/1996 | US5484936 Processes for the preparation of 1,3-bis(1,2,4-triazol-1-yl)-propan-2-ol derivatives |
| 01/16/1996 | US5484935 Pharmaceutical compounds |
| 01/16/1996 | US5484931 2-methyl-3-trifluoromethylaniline, methylation of 2-chloro-5-trifluoromethylpivalanilide |
| 01/16/1996 | US5484926 HIV protease inhibitors |
| 01/16/1996 | US5484921 Condensing an alkylamine with a chlorofluorcarboxyquinoline |
| 01/16/1996 | US5484833 Derivatives of non-steroidal anti-inflammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them |
| 01/16/1996 | US5484816 Stabilized vitamin a composition |
| 01/16/1996 | US5484811 Use of ethynyl alanine amino diol compounds for treatment of ophthalmic disorders |
| 01/16/1996 | US5484810 Tissue protective tocopherol analogs |
| 01/16/1996 | US5484809 Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid |
| 01/16/1996 | US5484808 Methods of inhibiting cell-cell adhesion |
| 01/16/1996 | US5484805 Heterocyclene derivatives |
| 01/16/1996 | US5484804 Perhydroisoindole derivatives as antagonists of substance P |
| 01/16/1996 | US5484803 Transcutaneous in vivo activation of photosensitive agents in blood |
| 01/16/1996 | US5484801 Pharmaceutical composition for inhibiting HIV protease |
| 01/16/1996 | US5484800 Lipid-based liquid medicinal composition |
| 01/16/1996 | US5484798 Benzothiopene compounds, compositions, and method of inhibiting restenosis |
| 01/16/1996 | US5484797 Naphthly compounds, intermediates, processes, compositions, and method for inhibiting endometrosis |
| 01/16/1996 | US5484796 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting aortal smooth muscle cell proliferation |